nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0789	0.126	CbGbCtD
Treprostinil—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0742	0.118	CbGbCtD
Treprostinil—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0742	0.118	CbGbCtD
Treprostinil—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0671	0.107	CbGbCtD
Treprostinil—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0671	0.107	CbGbCtD
Treprostinil—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0579	0.0925	CbGbCtD
Treprostinil—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0563	0.0898	CbGbCtD
Treprostinil—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0509	0.0812	CbGbCtD
Treprostinil—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0509	0.0812	CbGbCtD
Treprostinil—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0488	0.0779	CbGbCtD
Treprostinil—P2RY12—blood plasma—acquired immunodeficiency syndrome	0.011	0.132	CbGeAlD
Treprostinil—PTGIR—endothelium—acquired immunodeficiency syndrome	0.0079	0.0952	CbGeAlD
Treprostinil—PTGIR—blood plasma—acquired immunodeficiency syndrome	0.00702	0.0845	CbGeAlD
Treprostinil—P2RY12—blood—acquired immunodeficiency syndrome	0.00403	0.0485	CbGeAlD
Treprostinil—PPARD—lymphoid tissue—acquired immunodeficiency syndrome	0.00356	0.0429	CbGeAlD
Treprostinil—PPARD—digestive system—acquired immunodeficiency syndrome	0.00351	0.0423	CbGeAlD
Treprostinil—P2RY12—nervous system—acquired immunodeficiency syndrome	0.00327	0.0394	CbGeAlD
Treprostinil—P2RY12—central nervous system—acquired immunodeficiency syndrome	0.00315	0.0379	CbGeAlD
Treprostinil—PPARD—vagina—acquired immunodeficiency syndrome	0.0031	0.0374	CbGeAlD
Treprostinil—PPARD—lung—acquired immunodeficiency syndrome	0.00294	0.0354	CbGeAlD
Treprostinil—PPARD—nervous system—acquired immunodeficiency syndrome	0.00272	0.0327	CbGeAlD
Treprostinil—PTGIR—digestive system—acquired immunodeficiency syndrome	0.0027	0.0325	CbGeAlD
Treprostinil—PPARD—central nervous system—acquired immunodeficiency syndrome	0.00262	0.0315	CbGeAlD
Treprostinil—PTGIR—blood—acquired immunodeficiency syndrome	0.00257	0.031	CbGeAlD
Treprostinil—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00251	0.0302	CbGeAlD
Treprostinil—P2RY12—brain—acquired immunodeficiency syndrome	0.0025	0.0301	CbGeAlD
Treprostinil—PTGIR—spinal cord—acquired immunodeficiency syndrome	0.00248	0.0298	CbGeAlD
Treprostinil—PTGIR—lung—acquired immunodeficiency syndrome	0.00225	0.0271	CbGeAlD
Treprostinil—PTGIR—nervous system—acquired immunodeficiency syndrome	0.00209	0.0251	CbGeAlD
Treprostinil—PPARD—brain—acquired immunodeficiency syndrome	0.00208	0.025	CbGeAlD
Treprostinil—PTGIR—central nervous system—acquired immunodeficiency syndrome	0.00201	0.0242	CbGeAlD
Treprostinil—PPARD—lymph node—acquired immunodeficiency syndrome	0.00201	0.0242	CbGeAlD
Treprostinil—PTGIR—brain—acquired immunodeficiency syndrome	0.0016	0.0192	CbGeAlD
Treprostinil—PTGIR—lymph node—acquired immunodeficiency syndrome	0.00154	0.0186	CbGeAlD
Treprostinil—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000964	0.0116	CbGeAlD
Treprostinil—CYP2C9—blood—acquired immunodeficiency syndrome	0.000919	0.0111	CbGeAlD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000874	0.0346	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000804	0.0318	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000665	0.0263	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000612	0.0242	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—acquired immunodeficiency syndrome	0.000593	0.0235	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000529	0.0209	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000487	0.0193	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000479	0.0189	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000441	0.0174	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000415	0.0164	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000403	0.016	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—CCNT1—acquired immunodeficiency syndrome	0.000394	0.0156	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000372	0.0147	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000371	0.0147	CbGpPWpGaD
Treprostinil—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000365	0.00138	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000365	0.0144	CbGpPWpGaD
Treprostinil—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000364	0.00137	CcSEcCtD
Treprostinil—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000363	0.00137	CcSEcCtD
Treprostinil—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000363	0.00137	CcSEcCtD
Treprostinil—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000362	0.00137	CcSEcCtD
Treprostinil—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.00136	CcSEcCtD
Treprostinil—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000361	0.00136	CcSEcCtD
Treprostinil—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00136	CcSEcCtD
Treprostinil—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00036	0.00136	CcSEcCtD
Treprostinil—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000359	0.00135	CcSEcCtD
Treprostinil—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000359	0.00135	CcSEcCtD
Treprostinil—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000359	0.00135	CcSEcCtD
Treprostinil—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.00135	CcSEcCtD
Treprostinil—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000357	0.00135	CcSEcCtD
Treprostinil—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.00134	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000356	0.00134	CcSEcCtD
Treprostinil—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000356	0.00134	CcSEcCtD
Treprostinil—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000354	0.00134	CcSEcCtD
Treprostinil—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000354	0.00133	CcSEcCtD
Treprostinil—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.00133	CcSEcCtD
Treprostinil—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000354	0.00133	CcSEcCtD
Treprostinil—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.00133	CcSEcCtD
Treprostinil—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.00133	CcSEcCtD
Treprostinil—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000352	0.00133	CcSEcCtD
Treprostinil—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000352	0.00133	CcSEcCtD
Treprostinil—Rash—Didanosine—acquired immunodeficiency syndrome	0.000351	0.00132	CcSEcCtD
Treprostinil—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000351	0.00132	CcSEcCtD
Treprostinil—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00132	CcSEcCtD
Treprostinil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000351	0.00132	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00035	0.0138	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00035	0.0138	CbGpPWpGaD
Treprostinil—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000349	0.00132	CcSEcCtD
Treprostinil—Headache—Didanosine—acquired immunodeficiency syndrome	0.000349	0.00132	CcSEcCtD
Treprostinil—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00131	CcSEcCtD
Treprostinil—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000348	0.00131	CcSEcCtD
Treprostinil—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00131	CcSEcCtD
Treprostinil—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000347	0.00131	CcSEcCtD
Treprostinil—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000347	0.00131	CcSEcCtD
Treprostinil—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000346	0.00131	CcSEcCtD
Treprostinil—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.0013	CcSEcCtD
Treprostinil—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000346	0.0013	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000345	0.0137	CbGpPWpGaD
Treprostinil—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000345	0.0013	CcSEcCtD
Treprostinil—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000344	0.0013	CcSEcCtD
Treprostinil—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.0013	CcSEcCtD
Treprostinil—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000343	0.00129	CcSEcCtD
Treprostinil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000343	0.00129	CcSEcCtD
Treprostinil—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000342	0.00129	CcSEcCtD
Treprostinil—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000342	0.00129	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000341	0.0135	CbGpPWpGaD
Treprostinil—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00129	CcSEcCtD
Treprostinil—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000341	0.00128	CcSEcCtD
Treprostinil—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000341	0.00128	CcSEcCtD
Treprostinil—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000341	0.00128	CcSEcCtD
Treprostinil—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00034	0.00128	CcSEcCtD
Treprostinil—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00128	CcSEcCtD
Treprostinil—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00128	CcSEcCtD
Treprostinil—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.00128	CcSEcCtD
Treprostinil—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000337	0.00127	CcSEcCtD
Treprostinil—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000337	0.00127	CcSEcCtD
Treprostinil—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000337	0.00127	CcSEcCtD
Treprostinil—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00127	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000336	0.00127	CcSEcCtD
Treprostinil—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000336	0.00127	CcSEcCtD
Treprostinil—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00127	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000335	0.0133	CbGpPWpGaD
Treprostinil—Pain—Indinavir—acquired immunodeficiency syndrome	0.000334	0.00126	CcSEcCtD
Treprostinil—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.00126	CcSEcCtD
Treprostinil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.00125	CcSEcCtD
Treprostinil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.00125	CcSEcCtD
Treprostinil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000332	0.00125	CcSEcCtD
Treprostinil—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.00125	CcSEcCtD
Treprostinil—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000331	0.00125	CcSEcCtD
Treprostinil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000331	0.00125	CcSEcCtD
Treprostinil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000331	0.00125	CcSEcCtD
Treprostinil—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.00124	CcSEcCtD
Treprostinil—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.00124	CcSEcCtD
Treprostinil—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.00124	CcSEcCtD
Treprostinil—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00124	CcSEcCtD
Treprostinil—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00124	CcSEcCtD
Treprostinil—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00124	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000327	0.0129	CbGpPWpGaD
Treprostinil—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00123	CcSEcCtD
Treprostinil—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00123	CcSEcCtD
Treprostinil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000326	0.00123	CcSEcCtD
Treprostinil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.00123	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000325	0.0128	CbGpPWpGaD
Treprostinil—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.00122	CcSEcCtD
Treprostinil—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.00122	CcSEcCtD
Treprostinil—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000322	0.00121	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000322	0.00121	CcSEcCtD
Treprostinil—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.00121	CcSEcCtD
Treprostinil—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000321	0.00121	CcSEcCtD
Treprostinil—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.00121	CcSEcCtD
Treprostinil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000321	0.00121	CcSEcCtD
Treprostinil—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00121	CcSEcCtD
Treprostinil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00032	0.00121	CcSEcCtD
Treprostinil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00032	0.0012	CcSEcCtD
Treprostinil—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.0012	CcSEcCtD
Treprostinil—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.0012	CcSEcCtD
Treprostinil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000318	0.0012	CcSEcCtD
Treprostinil—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.0012	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000318	0.0126	CbGpPWpGaD
Treprostinil—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.0012	CcSEcCtD
Treprostinil—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.00119	CcSEcCtD
Treprostinil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000316	0.00119	CcSEcCtD
Treprostinil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000315	0.00119	CcSEcCtD
Treprostinil—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000315	0.00119	CcSEcCtD
Treprostinil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000315	0.00119	CcSEcCtD
Treprostinil—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.00119	CcSEcCtD
Treprostinil—PTGIR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000314	0.0124	CbGpPWpGaD
Treprostinil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000314	0.00118	CcSEcCtD
Treprostinil—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.00118	CcSEcCtD
Treprostinil—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.00118	CcSEcCtD
Treprostinil—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000313	0.00118	CcSEcCtD
Treprostinil—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.00118	CcSEcCtD
Treprostinil—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00118	CcSEcCtD
Treprostinil—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00117	CcSEcCtD
Treprostinil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.00117	CcSEcCtD
Treprostinil—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00117	CcSEcCtD
Treprostinil—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.00117	CcSEcCtD
Treprostinil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00116	CcSEcCtD
Treprostinil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00116	CcSEcCtD
Treprostinil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000308	0.00116	CcSEcCtD
Treprostinil—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00116	CcSEcCtD
Treprostinil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000307	0.00116	CcSEcCtD
Treprostinil—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000307	0.00116	CcSEcCtD
Treprostinil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000306	0.00115	CcSEcCtD
Treprostinil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000306	0.00115	CcSEcCtD
Treprostinil—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.00115	CcSEcCtD
Treprostinil—Rash—Stavudine—acquired immunodeficiency syndrome	0.000305	0.00115	CcSEcCtD
Treprostinil—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00115	CcSEcCtD
Treprostinil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000305	0.00115	CcSEcCtD
Treprostinil—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000304	0.00115	CcSEcCtD
Treprostinil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000304	0.00115	CcSEcCtD
Treprostinil—Headache—Stavudine—acquired immunodeficiency syndrome	0.000303	0.00114	CcSEcCtD
Treprostinil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000303	0.00114	CcSEcCtD
Treprostinil—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.00114	CcSEcCtD
Treprostinil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.00114	CcSEcCtD
Treprostinil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000302	0.00114	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000301	0.0119	CbGpPWpGaD
Treprostinil—Rash—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00113	CcSEcCtD
Treprostinil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00113	CcSEcCtD
Treprostinil—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.0003	0.00113	CcSEcCtD
Treprostinil—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.00113	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000299	0.0118	CbGpPWpGaD
Treprostinil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000298	0.00112	CcSEcCtD
Treprostinil—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.00112	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00112	CcSEcCtD
Treprostinil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000297	0.00112	CcSEcCtD
Treprostinil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00112	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000296	0.0117	CbGpPWpGaD
Treprostinil—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.00111	CcSEcCtD
Treprostinil—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00111	CcSEcCtD
Treprostinil—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00111	CcSEcCtD
Treprostinil—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.00111	CcSEcCtD
Treprostinil—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00111	CcSEcCtD
Treprostinil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.0011	CcSEcCtD
Treprostinil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.0011	CcSEcCtD
Treprostinil—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.0011	CcSEcCtD
Treprostinil—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000291	0.0011	CcSEcCtD
Treprostinil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.00109	CcSEcCtD
Treprostinil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000288	0.00109	CcSEcCtD
Treprostinil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.00108	CcSEcCtD
Treprostinil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000288	0.00108	CcSEcCtD
Treprostinil—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000287	0.00108	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00108	CcSEcCtD
Treprostinil—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.00108	CcSEcCtD
Treprostinil—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.00107	CcSEcCtD
Treprostinil—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00107	CcSEcCtD
Treprostinil—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000283	0.00107	CcSEcCtD
Treprostinil—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00106	CcSEcCtD
Treprostinil—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00106	CcSEcCtD
Treprostinil—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00028	0.00106	CcSEcCtD
Treprostinil—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00106	CcSEcCtD
Treprostinil—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00106	CcSEcCtD
Treprostinil—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.00105	CcSEcCtD
Treprostinil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.00105	CcSEcCtD
Treprostinil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.00105	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000278	0.011	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000278	0.011	CbGpPWpGaD
Treprostinil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000278	0.00105	CcSEcCtD
Treprostinil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000277	0.00104	CcSEcCtD
Treprostinil—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00104	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000275	0.0109	CbGpPWpGaD
Treprostinil—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.00103	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.00103	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000272	0.0108	CbGpPWpGaD
Treprostinil—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.00102	CcSEcCtD
Treprostinil—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00102	CcSEcCtD
Treprostinil—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00102	CcSEcCtD
Treprostinil—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000269	0.00101	CcSEcCtD
Treprostinil—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00101	CcSEcCtD
Treprostinil—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00101	CcSEcCtD
Treprostinil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000267	0.00101	CcSEcCtD
Treprostinil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000267	0.00101	CcSEcCtD
Treprostinil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00101	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000266	0.0105	CbGpPWpGaD
Treprostinil—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.000999	CcSEcCtD
Treprostinil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000265	0.000999	CcSEcCtD
Treprostinil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.000998	CcSEcCtD
Treprostinil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.000996	CcSEcCtD
Treprostinil—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000263	0.000992	CcSEcCtD
Treprostinil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.000985	CcSEcCtD
Treprostinil—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.000983	CcSEcCtD
Treprostinil—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000259	0.000977	CcSEcCtD
Treprostinil—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.000975	CcSEcCtD
Treprostinil—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000258	0.000974	CcSEcCtD
Treprostinil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.000974	CcSEcCtD
Treprostinil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.000974	CcSEcCtD
Treprostinil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.000969	CcSEcCtD
Treprostinil—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.000967	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000256	0.0101	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000256	0.0101	CbGpPWpGaD
Treprostinil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.000956	CcSEcCtD
Treprostinil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.000952	CcSEcCtD
Treprostinil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.000942	CcSEcCtD
Treprostinil—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00025	0.000941	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000249	0.00985	CbGpPWpGaD
Treprostinil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.000937	CcSEcCtD
Treprostinil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.000937	CcSEcCtD
Treprostinil—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000249	0.000937	CcSEcCtD
Treprostinil—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000247	0.000932	CcSEcCtD
Treprostinil—Rash—Indinavir—acquired immunodeficiency syndrome	0.000246	0.000929	CcSEcCtD
Treprostinil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000246	0.000928	CcSEcCtD
Treprostinil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000925	CcSEcCtD
Treprostinil—Headache—Indinavir—acquired immunodeficiency syndrome	0.000245	0.000923	CcSEcCtD
Treprostinil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.000921	CcSEcCtD
Treprostinil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.000911	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00024	0.00948	CbGpPWpGaD
Treprostinil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.000894	CcSEcCtD
Treprostinil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.000894	CcSEcCtD
Treprostinil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000885	CcSEcCtD
Treprostinil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.000884	CcSEcCtD
Treprostinil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000881	CcSEcCtD
Treprostinil—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000878	CcSEcCtD
Treprostinil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.000877	CcSEcCtD
Treprostinil—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000232	0.000875	CcSEcCtD
Treprostinil—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.000872	CcSEcCtD
Treprostinil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.000871	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000229	0.00907	CbGpPWpGaD
Treprostinil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.000851	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000225	0.00891	CbGpPWpGaD
Treprostinil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000847	CcSEcCtD
Treprostinil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000843	CcSEcCtD
Treprostinil—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.00084	CcSEcCtD
Treprostinil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000839	CcSEcCtD
Treprostinil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000839	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000222	0.0088	CbGpPWpGaD
Treprostinil—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.000834	CcSEcCtD
Treprostinil—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000827	CcSEcCtD
Treprostinil—PPARD—Metabolism—TAT—acquired immunodeficiency syndrome	0.000217	0.0086	CbGpPWpGaD
Treprostinil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000814	CcSEcCtD
Treprostinil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000811	CcSEcCtD
Treprostinil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000811	CcSEcCtD
Treprostinil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.0008	CcSEcCtD
Treprostinil—P2RY12—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000212	0.00838	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000212	0.00838	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000212	0.00837	CbGpPWpGaD
Treprostinil—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000791	CcSEcCtD
Treprostinil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000784	CcSEcCtD
Treprostinil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000783	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000207	0.0082	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000207	0.00819	CbGpPWpGaD
Treprostinil—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000777	CcSEcCtD
Treprostinil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000776	CcSEcCtD
Treprostinil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000774	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000205	0.0081	CbGpPWpGaD
Treprostinil—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000772	CcSEcCtD
Treprostinil—P2RY12—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000202	0.00798	CbGpPWpGaD
Treprostinil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000754	CcSEcCtD
Treprostinil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000748	CcSEcCtD
Treprostinil—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000747	CcSEcCtD
Treprostinil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000747	CcSEcCtD
Treprostinil—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000743	CcSEcCtD
Treprostinil—PTGIR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000195	0.00771	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000195	0.00771	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000195	0.0077	CbGpPWpGaD
Treprostinil—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000732	CcSEcCtD
Treprostinil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000719	CcSEcCtD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000191	0.00754	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00019	0.00753	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.00019	0.00751	CbGpPWpGaD
Treprostinil—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000713	CcSEcCtD
Treprostinil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000712	CcSEcCtD
Treprostinil—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000709	CcSEcCtD
Treprostinil—P2RY12—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000187	0.0074	CbGpPWpGaD
Treprostinil—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000704	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000186	0.00735	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000185	0.00731	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000181	0.00718	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000179	0.0071	CbGpPWpGaD
Treprostinil—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000672	CcSEcCtD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000175	0.00694	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000172	0.00681	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000167	0.0066	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.000164	0.00648	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000161	0.00637	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000148	0.00587	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000145	0.00576	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000145	0.00574	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000142	0.00561	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000134	0.00529	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IL6—acquired immunodeficiency syndrome	0.000132	0.00523	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000131	0.00517	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000128	0.00506	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000127	0.00504	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000122	0.00484	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000122	0.00484	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00012	0.00474	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00012	0.00474	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000118	0.00465	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000117	0.00463	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000116	0.00457	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000112	0.00445	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000112	0.00445	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000111	0.00437	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00011	0.00436	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00011	0.00436	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000109	0.0043	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000109	0.0043	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000106	0.00421	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000102	0.00402	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.0001	0.00396	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.0001	0.00396	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ALB—acquired immunodeficiency syndrome	9.25e-05	0.00366	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.1e-05	0.0036	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.97e-05	0.00355	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—acquired immunodeficiency syndrome	8.51e-05	0.00337	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.51e-05	0.00337	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.38e-05	0.00332	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.34e-05	0.0033	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.27e-05	0.00327	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.25e-05	0.00327	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.2e-05	0.00325	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.14e-05	0.00322	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.61e-05	0.00301	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.55e-05	0.00299	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.55e-05	0.00299	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—acquired immunodeficiency syndrome	7.5e-05	0.00297	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.49e-05	0.00297	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.45e-05	0.00295	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.95e-05	0.00275	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—acquired immunodeficiency syndrome	6.9e-05	0.00273	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.85e-05	0.00271	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.83e-05	0.0027	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.42e-05	0.00254	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.42e-05	0.00254	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.28e-05	0.00249	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.91e-05	0.00234	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.91e-05	0.00234	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.88e-05	0.00193	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.81e-05	0.0019	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.74e-05	0.00188	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.49e-05	0.00178	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.43e-05	0.00175	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.4e-05	0.00174	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	4.37e-05	0.00173	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.36e-05	0.00173	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.3e-05	0.0017	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.05e-05	0.0016	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.96e-05	0.00157	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—acquired immunodeficiency syndrome	3.79e-05	0.0015	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	3.71e-05	0.00147	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.54e-05	0.00101	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.53e-05	0.001	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.34e-05	0.000926	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.33e-05	0.000921	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.71e-05	0.000677	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.49e-05	0.000591	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.38e-05	0.000544	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	7.62e-06	0.000301	CbGpPWpGaD
